Australia bans compounded weight-loss drugs, including Ozempic and Mounjaro replicas, due to safety concerns and hospitalizations.
Australia is banning compounded weight-loss drugs, including replicas of popular medications like Ozempic and Mounjaro, over safety concerns. Approximately 20,000 Australians have been using these imitation drugs, which have led to a rise in hospitalizations due to adverse effects. The drugs are compounded medications tailored for individual patients and are not approved by the Therapeutic Goods Administration for mass production and use.
May 21, 2024
18 Articles